MedPath

Coventry Outcomes Study of Seniors (COSS): A Comparative Effectiveness Study to Evaluate the Effect of a Multidisciplinary Team's Intervention on the Incidence of Nonelective Hospitalizations in a Medicare Population

Not Applicable
Terminated
Conditions
Heart Failure
Chronic Obstructive Pulmonary Disease
Cardiovascular Disease
Diabetes
Osteoporosis
Interventions
Other: Usual case management and pharmacy management as provided by the health Plan and the pharmacy benefit manager
Other: Multidisciplinary team interventions
Other: Multidisciplinary team bimonthly visits either in person or via telephone.
Registration Number
NCT01014884
Lead Sponsor
Medco Health Solutions, Inc.
Brief Summary

The investigators are studying the impact of the interventions of a multidisciplinary team (MDT) - consisting of a Coventry case manager, social worker, and medical director, alongside a Medco specialist pharmacist - on the hospitalization rates of high risk seniors with chronic conditions, compared with a usual care approach. The study will also examine the impact on quality of life, medication adherence, medical costs, hospital readmission rates, and a variety of other important measures. The outcome of COSS may support a means to further enhance and develop a comprehensive care model program by leveraging the partnership between a health plan and a pharmacy benefit manager.

Detailed Description

The multidisciplinary team will provide face-to-face visits in a home setting with interventions that focus on five key areas: care transitions, self-management, care coordination, pharmacy and prevention, all designed to support high-risk Medicare members and their relationship with their primary care providers. If the study proves to reduce hospitalizations in the senior population, it could provide important guidance for future efforts to reduce the cost and improve the quality of care for seniors with chronic conditions.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
2150
Inclusion Criteria
  • Inouye Risk Score >3 calculated on Coventry Claims
  • Medicare Advantage beneficiaries age > 65 years
  • Continuous eligibility > 12 months prior to study
  • Ability to be contacted via telephone
  • Subject is willing and able to provide informed consent
  • Willing to comply with all study procedures and be available for the duration of the study
Exclusion Criteria
  • Active cancer treatment (i.e. chemotherapy or radiation) in the past 6 months
  • Living anywhere other than a community setting [i.e. Skilled nursing facility (SNF)]
  • Just-In-Time (JIT) Members
  • Members with a geographic location > 60 from either St. Louis or Kansas City, MO.
  • Solid organ transplant recipients
  • Active enrollment in another clinical research study

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Control GroupUsual case management and pharmacy management as provided by the health Plan and the pharmacy benefit managerThe control group will receive usual care as provided by your Health Plan.
Intervention groupMultidisciplinary team interventionsAdditional visits will be conducted by a member of the multidisciplinary team (case manager/nurse, social worker and/or pharmacist that will be either face to face or by telephone.
Intervention groupMultidisciplinary team bimonthly visits either in person or via telephone.Additional visits will be conducted by a member of the multidisciplinary team (case manager/nurse, social worker and/or pharmacist that will be either face to face or by telephone.
Primary Outcome Measures
NameTimeMethod
Determine the impact of multidisciplinary team interventions in reducing the rate of non-elective hospitalizations over a 12 month period compared to usual care12 months
Secondary Outcome Measures
NameTimeMethod
Determine the impact of multidisciplinary team interventions on the rate of emergency room visits not resulting in hospitalization in a 24 hour period or less.12 months
Determine the impact of multidisciplinary team interventions versus usual care on health-related quality of life (HR-QOL)12 months
Determine the impact of MDT interventions versus usual care on inpatient costs associated with non-elective hospital events [rehabilitation, physician, incurred but not reported (IBNR)]12 months
Determine the impact of multidisciplinary team interventions versus usual care on total outpatient costs (physician, pharmacy,rehabilitation)12 months
Determine the impact of multidisciplinary team interventions versus usual care on satisfaction with care12 months
Determine the impact of multidisciplinary team interventions versus usual care on rate of non-elective hospitalizations by chronic condition12 months
Determine the impact of multidisciplinary team interventions versus usual care on non-elective hospital readmissions at 30, 60, and 90 days following the first non-elective hospitalization event12
Determine the impact of multidisciplinary team interventions versus usual care on the length of stay (LOS) of each non-elective hospitalization12 months
© Copyright 2025. All Rights Reserved by MedPath